Litcius/Paper detail

Neighborhood socioeconomic status and low‐value breast cancer care

JC Chen, Yaming Li, James L. Fisher, Oindrila Bhattacharyya, Allan Tsung, Samilia Obeng‐Gyasi

2022Journal of Surgical Oncology11 citationsDOIOpen Access PDF

Abstract

BACKGROUND: The objective of this study is to examine the association between neighborhood socioeconomic status (nSES) and receipt of low-value breast cancer procedures. METHODS: Patients with breast cancer diagnosed between 2010 and 2016 were identified in the Surveillance, Epidemiology, and End Results (SEER) Program. Low value procedures included: (1) axillary lymph node dissection (ALND) for patients with limited nodal disease receiving breast conservation therapy (BCT); (2) contralateral prophylactic mastectomies (CPM); and (3) sentinel lymph node biopsies (SLNB) in patients ≥70 years old with clinically node negative early-stage hormone-positive breast cancer. The cohort was divided by nSES. Univariable and multivariable logistic regression analysis compared the groups. RESULTS: The study included 412 959 patients. Compared to patients in high nSES areas, residing in neighborhoods with low nSES (odd ratio [OR] 2.20, 95% confidence interval [CI] 2.0-2.42) and middle nSES (OR 1.42, 95% CI 1.20-1.56) was associated with a higher probability of undergoing low value ALND. Conversely, patients in low SES neighborhoods were less likely to receive low value SLNB (OR 0.89, 95% CI 0.85-0.94) or CPM than (low nSES OR 0.75, 95% CI 0.73-0.77); middle nSES OR 0.91 (0.89-0.92) those in high SES neighborhoods. CONCLUSION: In the SEER Program, low nSES was associated with a lower probability of low value procedures except for ALND utilization.

Topics & Concepts

MedicineBreast cancerConfidence intervalSocioeconomic statusAxillary Lymph Node DissectionOdds ratioSentinel lymph nodeCohortLogistic regressionEpidemiologyCohort studyInternal medicineCancerSurgeryPopulationEnvironmental healthHealthcare cost, quality, practicesGlobal Cancer Incidence and ScreeningEconomic and Financial Impacts of Cancer